Ha habido 50 transacciones internas recientes registradas para Viridian Therapeutics, Inc. (VRDN), incluyendo 31 compras y 13 ventas. El total de compras internas fue valorado en $70.08M y el total de ventas internas en $4.81M.
Internos destacados con actividad reciente incluyen Beetham Thomas W., Mahoney Stephen F., Harmon Seth. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — VRDN
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-03-03 |
Beetham Thomas W. |
Chief Operating Officer |
Retención Fiscal de RSU |
3,138 |
$29.32 |
$92.01K |
13,271 |
| 2026-03-03 |
Mahoney Stephen F. |
President and CEO |
Retención Fiscal de RSU |
7,627 |
$29.32 |
$223.62K |
33,130 |
| 2026-03-03 |
Harmon Seth |
Chief Financial Officer |
Retención Fiscal de RSU |
2,091 |
$29.32 |
$61.31K |
7,790 |
| 2026-03-03 |
Tousignant Jennifer |
Chief Legal Officer |
Retención Fiscal de RSU |
1,724 |
$29.32 |
$50.55K |
3,445 |
| 2026-03-03 |
Beetham Thomas W. |
Chief Operating Officer |
Retención Fiscal de RSU |
3,048 |
$30.19 |
$92.02K |
13,361 |
| 2026-03-03 |
Mahoney Stephen F. |
President and CEO |
Retención Fiscal de RSU |
7,408 |
$30.19 |
$223.65K |
33,349 |
| 2026-03-03 |
Harmon Seth |
Chief Financial Officer |
Retención Fiscal de RSU |
2,031 |
$30.19 |
$61.32K |
7,850 |
| 2026-03-03 |
Tousignant Jennifer |
Chief Legal Officer |
Retención Fiscal de RSU |
1,675 |
$30.19 |
$50.57K |
3,494 |
| 2026-03-02 |
Beetham Thomas W. |
Chief Operating Officer |
Concesión de RSU |
35,300 |
- |
- |
35,300 |
| 2026-03-02 |
Mahoney Stephen F. |
President and CEO |
Concesión de RSU |
111,900 |
- |
- |
111,900 |
| 2026-03-02 |
Tripuraneni Radhika |
Chief Medical Officer |
Concesión de RSU |
19,150 |
- |
- |
19,150 |
| 2026-03-02 |
Harmon Seth |
Chief Financial Officer |
Concesión de RSU |
20,550 |
- |
- |
20,550 |
| 2026-03-02 |
Tousignant Jennifer |
Chief Legal Officer |
Concesión de RSU |
23,850 |
- |
- |
23,850 |
| 2025-12-31 |
Tousignant Jennifer |
Chief Legal Officer |
Venta Informativa |
2,272 |
$31.16 |
$70.8K |
- |
| 2025-10-23 |
Fairmount Funds Management Llc |
10 Percent Owner |
Compra Informativa |
454,545 |
$22.00 |
$10M |
3,914,458 |
| 2025-07-01 |
Morris Arlene |
Director |
Concesión de RSU |
21,000 |
$14.47 |
$303.87K |
21,000 |
| 2025-07-01 |
Ajer Jeffrey Robert |
Director |
Concesión de RSU |
21,000 |
$14.47 |
$303.87K |
21,000 |
| 2025-07-01 |
Moses Jennifer K. |
Director |
Concesión de RSU |
21,000 |
$14.47 |
$303.87K |
21,000 |
| 2025-07-01 |
Cain Christopher W. |
Director |
Concesión de RSU |
21,000 |
$14.47 |
$303.87K |
21,000 |
| 2025-07-01 |
Kiselak Tomas |
Director |
Concesión de RSU |
21,000 |
$14.47 |
$303.87K |
21,000 |
| 2025-07-01 |
Gheuens Sarah |
Director |
Concesión de RSU |
21,000 |
$14.47 |
$303.87K |
21,000 |
| 2025-06-10 |
Fairmount Funds Management Llc |
10 Percent Owner |
Ejercicio de Opciones (Venta) |
12,500 |
$12.31 |
$153.88K |
- |
| 2025-06-09 |
Fairmount Funds Management Llc |
10 Percent Owner |
Ejercicio de Opciones (Venta) |
1,600 |
$7.80 |
$12.48K |
- |
| 2025-04-07 |
Ajer Jeffrey Robert |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-04-07 |
Ajer Jeffrey Robert |
Director |
Concesión de RSU |
42,000 |
$11.78 |
$494.76K |
42,000 |
| 2025-03-10 |
Tripuraneni Radhika |
Chief Medical Officer |
Desconocido |
40,000 |
$13.21 |
$528.4K |
- |
| 2025-03-10 |
Tripuraneni Radhika |
Chief Medical Officer |
Concesión de RSU |
310,700 |
$15.58 |
$4.84M |
310,700 |
| 2025-03-10 |
Cain Christopher W. |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-03-10 |
Cain Christopher W. |
Director |
Concesión de RSU |
42,000 |
$15.58 |
$654.36K |
42,000 |
| 2025-03-03 |
Beetham Thomas W. |
Chief Operating Officer |
Concesión de RSU |
37,636 |
- |
- |
37,636 |
| 2025-03-03 |
Mahoney Stephen F. |
President and CEO |
Concesión de RSU |
73,428 |
- |
- |
73,428 |
| 2025-03-03 |
Harmon Seth |
Chief Financial Officer |
Concesión de RSU |
25,068 |
- |
- |
25,068 |
| 2025-03-03 |
Tousignant Jennifer |
Chief Legal Officer |
Concesión de RSU |
20,679 |
- |
- |
20,679 |
| 2025-03-03 |
Harmon Seth |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-03-03 |
Tousignant Jennifer |
Officer |
Desconocido |
- |
- |
- |
- |
| 2024-09-27 |
Beetham Thomas W. |
Chief Operating Officer |
Compra Informativa |
5,000 |
$23.41 |
$117.05K |
6,000 |
| 2024-09-27 |
Mahoney Stephen F. |
President and CEO |
Compra Informativa |
21,400 |
$23.33 |
$499.26K |
21,400 |
| 2024-09-13 |
Fairmount Funds Management Llc |
10 Percent Owner |
Compra Informativa |
1,600,000 |
$18.75 |
$30M |
3,445,813 |
| 2024-06-26 |
Morris Arlene |
Director |
Concesión de RSU |
21,000 |
$12.31 |
$258.51K |
21,000 |
| 2024-06-26 |
Harwin Peter Evan |
Director |
Concesión de RSU |
21,000 |
$12.31 |
$258.51K |
21,000 |
| 2024-06-26 |
Moses Jennifer K. |
Director |
Concesión de RSU |
21,000 |
$12.31 |
$258.51K |
21,000 |
| 2024-06-26 |
Kiselak Tomas |
Director |
Concesión de RSU |
21,000 |
$12.31 |
$258.51K |
21,000 |
| 2024-06-26 |
Gheuens Sarah |
Director |
Concesión de RSU |
21,000 |
$12.31 |
$258.51K |
21,000 |
| 2024-03-28 |
Fairmount Funds Management Llc |
10 Percent Owner |
Otro (Venta) |
5,859 |
- |
- |
- |
| 2024-02-12 |
Tousignant Jennifer |
Officer |
Desconocido |
- |
- |
- |
- |
| 2024-02-12 |
Tousignant Jennifer |
Chief Legal Officer |
Concesión de RSU |
290,000 |
$19.68 |
$5.71M |
290,000 |
| 2024-02-05 |
Ciulla Thomas |
Chief Medical Officer |
Concesión de RSU |
50,000 |
$18.70 |
$935K |
50,000 |
| 2024-01-22 |
Fairmount Funds Management Llc |
10 Percent Owner, Other: See Remarks |
Compra Informativa |
476,190 |
$21.00 |
$10M |
1,839,954 |
| 2024-01-03 |
Ciulla Thomas |
Chief Medical Officer |
Disposición |
270,000 |
$13.76 |
$3.72M |
- |
| 2023-11-10 |
Harmon Seth |
See Remarks |
Concesión de RSU |
270,000 |
$13.76 |
$3.72M |
270,000 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
